These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8380131)

  • 41. [Medical treatment for stage III non-small-cell lung cancer (NSCLC)].
    Okamoto H; Watanabe K
    Gan To Kagaku Ryoho; 2007 Jun; 34(6):841-8. PubMed ID: 17565244
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction chemotherapy for resectable non-small-cell lung cancer.
    Patel JD; Blum MG; Argiris A
    Oncology (Williston Park); 2004 Nov; 18(13):1591-602; discussion 1602-3, 1606, 1611-2. PubMed ID: 15648293
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC.
    Pezzetta E; Stupp R; Zouhair A; Guillou L; Taffé P; von Briel C; Krueger T; Ris HB
    Eur J Cardiothorac Surg; 2005 Jun; 27(6):1092-8. PubMed ID: 15896624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Postoperative adjuvant therapy for 189 patients with completely resected non-small cell lung cancer of stage III(A)].
    Li Q; Gao JM; Liang PY; Xie FY; Liu GZ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1463-6. PubMed ID: 15566658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II-IIIA non-small cell lung cancer: study protocol for a randomized controlled trial.
    Saka H; Kitagawa C; Ichinose Y; Takenoyama M; Ibata H; Kato T; Takami K; Yamashita M; Maeda T; Takeo S; Ueda H; Okabayashi K; Nagashima S; Oka T; Kouso H; Fukuyama S; Yoshimoto K; Shimokawa M; Saito AM; Ito S
    Trials; 2017 Sep; 18(1):429. PubMed ID: 28915900
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.
    Rapp E; Pater JL; Willan A; Cormier Y; Murray N; Evans WK; Hodson DI; Clark DA; Feld R; Arnold AM
    J Clin Oncol; 1988 Apr; 6(4):633-41. PubMed ID: 2833577
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The future of adjuvant chemotherapy for resected non-small cell lung cancer.
    Vansteenkiste JF; Schildermans RH
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):165-75. PubMed ID: 15757448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adjuvant cisplatin-based chemotherapy for resected NSCLC: one size fits all?
    Geiger S; Schlemmer M; Heinemann V; Stemmler HJ
    Anticancer Drugs; 2010 Oct; 21(9):799-804. PubMed ID: 20679887
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjuvant chemotherapy in resected non-small cell lung cancer.
    Cangiano R
    Rays; 2004; 29(4):435-7. PubMed ID: 15852732
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?
    Le Chevalier T
    Ann Oncol; 2010 Oct; 21 Suppl 7():vii196-8. PubMed ID: 20943614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial.
    Waller D; Peake MD; Stephens RJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG
    Eur J Cardiothorac Surg; 2004 Jul; 26(1):173-82. PubMed ID: 15200998
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pre-operative chemotherapy in early stage resectable non-small-cell lung cancer: a randomized feasibility study justifying a multicentre phase III trial.
    de Boer RH; Smith IE; Pastorino U; O'Brien ME; Ramage F; Ashley S; Goldstraw P
    Br J Cancer; 1999 Mar; 79(9-10):1514-8. PubMed ID: 10188899
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adjuvant Chemotherapy in Resected Stage II Non-small Cell Lung Cancer: Evaluating the Impact of Dose Intensity and Time to Treatment.
    Ramsden K; Laskin J; Ho C
    Clin Oncol (R Coll Radiol); 2015 Jul; 27(7):394-400. PubMed ID: 25800720
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The benefit of adjuvant treatment for resected locally advanced non-small-cell lung cancer. The Lung Cancer Study Group.
    J Clin Oncol; 1988 Jan; 6(1):9-17. PubMed ID: 2891798
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A randomized trial of mitomycin/ifosfamide/cisplatin preoperative chemotherapy plus surgery versus surgery alone in stage IIIA non-small cell lung cancer.
    Rosell R; Maestre J; Font A; Moreno I; Molina F; Milla A; Gómez-Codina J; Camps C
    Semin Oncol; 1994 Jun; 21(3 Suppl 4):28-33. PubMed ID: 8209274
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancer.
    Keller SM; Vangel MG; Adak S; Wagner H; Schiller JH; Herskovic A; Komaki R; Perry MC; Marks RS; Livingston RB; Johnson DH
    Lung Cancer; 2002 Sep; 37(3):303-9. PubMed ID: 12234700
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The ALPI Trial: the Italian/European experience with adjuvant chemotherapy in resectable non-small lung cancer.
    Scagliotti GV
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5011s-5016s. PubMed ID: 16000605
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The current status of adjuvant chemotherapy for resected non-small cell lung cancer.
    Socinski MA
    Semin Oncol; 1999 Oct; 26(5 Suppl 15):27-33. PubMed ID: 10566608
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effectiveness of adjuvant chemotherapy in patient with early stages of non-small cell lung cancer depending on proliferation index of tumor].
    Kolesnik AP
    Lik Sprava; 2014; (1-2):110-7. PubMed ID: 24908971
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomised study of adjuvant chemotherapy for completely resected p-stage I-IIIA non-small cell lung cancer.
    Nakagawa K; Tada H; Akashi A; Yasumitsu T; Iuchi K; Taki T; Kodama K;
    Br J Cancer; 2006 Oct; 95(7):817-21. PubMed ID: 16969350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.